As a regulatory disclosure norm, listed companies are required to inform the stock exchanges upon change in shareholding to the tune of 5 per cent and above.Divis Laboratories is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports.
